The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global inhalable drugs market is expected to grow from $31.20 billion in 2022 to $33.29 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The inhalable drugs market is expected to reach $42.76 billion in 2027 at a CAGR of 6.5%.

North America held the largest inhalable drugs market share, and Asia-Pacific was the fastest-growing region in 2022.

Inhalable Drugs Market Driver
The increasing prevalence of respiratory diseases is expected to propel the growth of the inhalable drug market going forward. Respiratory diseases are medical conditions that affect the respiratory system, which includes the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. Inhalable drugs are a crucial and effective treatment option for several respiratory disorders as they deliver medication directly to the lungs. For instance, in June 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, there were approximately 6,551 deaths or 135 deaths per 100,000 population caused by respiratory chronic conditions in Australia in 2021, representing 27.1% of all deaths. Furthermore, chronic obstructive pulmonary disease (COPD) accounted for 2.6% of underlying-cause respiratory deaths, respectively. Therefore, the increasing prevalence of respiratory diseases will drive the future inhalable drug market.

View More On The Inhalable Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report

Prominent Inhalable Drugs Market Trend
Product innovations are a key trend gaining popularity in the inhalable drug market. Major companies operating in the inhalable drug market are focused on advances in inhalable drugs to sustain their position in the market. For instance, in July 2022, DMV-Fonterra Excipients GmbH & Co. KG, a Germany-based pharma company, expanded its dry powder inhalation (DPI) portfolio with the launch of Lactohale 400. This new grade can be customized to meet specific pharmaceutical company needs and developed jointly with formulators to ensure patient outcomes. The extensive spectrum of lactose-based additives is intended to provide appropriate characteristics for various inhaled therapies. Lactohale 400 is a crushed, dry lactose type suited to DPI applications requiring high flow and cohesiveness. Its anhydrous nature sets it apart from commonly used lactose carriers and offers a different aerosolization performance than lactose monohydrate with the same particle size.

Inhalable Drugs Market Prominent Players
Major players in the inhalable drugs market are Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, AstraZeneca plc, GlaxoSmithKline Plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH,Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Mylan N.V., Catalent Inc., Sumitomo Pharma Co. Ltd., Intertek Group plc, AptarGroup Inc., Cipla Inc., Glenmark Pharmaceuticals Inc., Piramal Pharma Ltd., Zambon S.p.A., Sunovion Pharmaceuticals Inc., Nelson Laboratories LLC, Vectura Group Limited, Abiogen Pharma, Quotient Sciences, AeroGen Pharma, Care Fusion Corporation, Alaxia S.A.S., Pharmaxis Ltd., Avalyn Pharma Inc., and TFF Pharmaceuticals Inc.

Request A Sample Of The Global Inhalable Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12490&type=smp

Key Inhalable Drugs Market Segments
The global inhalable drugs market is segmented –
1) By Product: Aerosol, Dry Powder Formulation, Spray
2) By Distribution Channel: Hospital Pharmacy, Pharmacy Stores, Other Distribution Channels
3) By Application: Respiratory Diseases, Non-Respiratory Diseases
4) By End Users: Adults, Pediatric, Geriatric

The Inhalable Drugs Global Market Report 2023  provides a comprehensive overview on the inhalable drugs market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the inhalable drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Drugs For Erectile Dysfunction Global Market Report 2023
Drugs For Benign Prostatic Hypertrophy Global Market Report 2023
Bladder Cancer Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model